REQUEST A DEMO
Total
USD $0.00
Search more companies

Jetpharma Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores | All Other Miscellaneous Ambulatory Health Care Services
Full name: Jetpharma Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Jetpharma Sdn. Bhd. is a company in Malaysia, with a head office in Puchong. It operates in the Pharmacies and Drug Stores industry. The company was established on February 28, 2004. In 2022, the company reported a net sales revenue increase of 13.29%. Its total assets grew by 3.58% over the same period. The net profit margin of Jetpharma Sdn. Bhd. decreased by 5.07% in 2022.

Headquarters
No. 13 Jalan Rajawali 2, Bandar Puchong Jaya
Puchong; Selangor; Postal Code: 47100

Contact Details: Purchase the Jetpharma Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Jetpharma Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Jetpharma Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Jetpharma Sdn. Bhd. report to view the information.
Incorporation Date:
February 28, 2004
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
99%
Purchase this report to view the information.
1%
Subsidiaries
Gopharma Sdn. Bhd.
70%
Company Performance
Financial values in the chart are available after Jetpharma Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
13.29%
Total operating revenue
13.29%
Operating profit (EBIT)
-25.33%
EBITDA
-23.94%
Net Profit (Loss) for the Period
-28.32%
Total assets
3.58%
Total equity
11.71%
Operating Profit Margin (ROS)
-6.31%
Net Profit Margin
-5.07%
Return on Equity (ROE)
-6.6%
Debt to Equity Ratio
-7.26%
Quick Ratio
6.96%
Cash Ratio
2.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?